Apolipoprotein (apo) E and the two B apolipoproteins, apoB48 and apoB100, are important proteins in human lipoprotein metabolism. Commonly occurring polymorphisms in the genes for apoE and apoB result in amino acid substitutions that produce readily detectable phenotypic differences in these proteins. We studied changes in apoE and apoB phenotypes before and after liver transplantation to gain new insights into apolipoprotein physiology. In all 29 patients that we studied, the postoperative serum apoE phenotype of the recipient, as assessed by isoelectric focusing, converted virtually completely to that of the donor, providing evidence that greater than 90% of the apoE in the plasma is synthesized by the liver. In contrast, the cerebrospinal fluid apoE phenotype did not change to the donor's phenotype after liver transplantation, indicating that most of the apoE in CSF cannot be derived from the plasma pool and therefore must be synthesized locally. The apoB100 phenotype (assessed with immunoassays using monoclonal antibody MB19, an antibody that detects a two-allele polymorphism in apoB) invariably converted to the phenotype of the donor. In four normolipidemic patients, we determined the MB19 phenotype of both the apoB100 and apoB48 in the "chylomicron fraction" isolated from plasma 3 h after a fat-rich meal. Interestingly, the apoB100 in the chylomicron fraction invariably had the phenotype of the donor, indicating that the vast majority of the large, triglyceride-rich apoB100-containing lipoproteins that appear in the plasma after a fat-rich meal are actually VLDL of hepatic origin. The MB19 phenotype of the apoB48 in the plasma chylomicron fraction did not change after liver transplantation, indicating that almost all of the apoB48 in plasma chylomicrons is derived from the intestine. These results were consistent with our immunocytochemical studies on intestinal biopsy specimens of organ donors; using apoB-specific monoclonal antibodies, we found evidence for apoB48, but not apoB100, in donor intestinal biopsy specimens.
M F Linton, R Gish, S T Hubl, E Bütler, C Esquivel, W I Bry, J K Boyles, M R Wardell, S G Young
Title and authors | Publication | Year |
---|---|---|
Association between apolipoprotein E ε4 status and the risk of Alzheimer’s disease: a meta-analysis
Ren Z, Guan Z, Guan Q, Guan H, Guan H |
BMC Neuroscience | 2025 |
The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms
Savulescu-Fiedler I, Dorobantu-Lungu LR, Dragosloveanu S, Benea SN, Dragosloveanu CD, Caruntu A, Scheau AE, Caruntu C, Scheau C |
Current Issues in Molecular Biology | 2025 |
HDL-replacement therapy: From traditional to emerging clinical applications
Sirtori CR, Cincotto G, Castiglione S, Pavanello C |
Atherosclerosis Plus | 2025 |
APOE genotype dictates lipidomic signatures in primary human hepatocytes.
Almeida FC, Patra K, Giannisis A, Niesnerova A, Nandakumar R, Ellis E, Oliveira TG, Nielsen HM |
Journal of lipid research | 2024 |
Insights into the roles of Apolipoprotein E in adipocyte biology and obesity.
Jiang CL, Lin FJ |
International Journal of Obesity | 2024 |
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
McInvale JJ, Canoll P, Hargus G |
Brain Pathology | 2024 |
Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells
Kreutzer E, Short JL, Nicolazzo JA |
Pharmaceutical Research | 2024 |
Multifaceted roles of APOE in Alzheimer disease.
Jackson RJ, Hyman BT, Serrano-Pozo A |
Nature reviews. Neurology | 2024 |
Lipoprotein Particles in Cerebrospinal Fluid
Tsujita M, Melchior JT, Yokoyama S |
Arteriosclerosis, thrombosis, and vascular biology | 2024 |
Body Composition and Alzheimer’s Disease: A Holistic Review
Frank G, Gualtieri P, Cianci R, Caldarelli M, Palma R, De Santis GL, Porfilio C, Nicoletti F, Bigioni G, Di Renzo L |
International Journal of Molecular Sciences | 2024 |
Pathways to Alzheimer's Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health.
Laslo A, Laslo L, Arbănași EM, Ujlaki-Nagi AA, Chinezu L, Ivănescu AD, Arbănași EM, Cărare RO, Cordoș BA, Popa IA, Brînzaniuc K |
Pathophysiology : the official journal of the International Society for Pathophysiology | 2024 |
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.
Narasimhan S, Holtzman DM, Apostolova LG, Cruchaga C, Masters CL, Hardy J, Villemagne VL, Bell J, Cho M, Hampel H |
Nature neuroscience | 2024 |
Behavioral and cognitive performance of humanized APOEε3/ε3 liver mice in relation to plasma apolipoprotein E levels.
Kessler K, Giannisis A, Bial G, Foquet L, Nielsen HM, Raber J |
Scientific Reports | 2023 |
Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
Sun YY, Wang Z, Huang HC |
Cellular and Molecular Neurobiology | 2023 |
Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment.
Giannisis A, Al-Grety A, Carlsson H, Howell JC, Hu WT, Kultima K, Nielsen HM |
Alzheimer's research & therapy | 2023 |
Apolipoprotein E in lipid metabolism and neurodegenerative disease.
Yang LG, March ZM, Stephenson RA, Narayan PS |
Trends in endocrinology and metabolism: TEM | 2023 |
ApoE expression in macrophages communicates immunometabolic signaling that controls hyperlipidemia-driven hematopoiesis & inflammation via extracellular vesicles.
Phu TA, Ng M, Vu NK, Gao AS, Raffai RL |
Journal of Extracellular Vesicles | 2023 |
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury.
Laskowitz DT, Van Wyck DW |
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023 |
Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health
Merrill NJ, Davidson WS, He Y, Díaz Ludovico I, Sarkar S, Berger MR, McDermott JE, Van Eldik LJ, Wilcock DM, Monroe ME, Kyle JE, Bruce KD, Heinecke JW, Vaisar T, Raber J, Quinn JF, Melchior JT |
Science Advances | 2023 |
Alzheimer's Disease: Causal Effect between Obesity and APOE Gene Polymorphisms.
Zhao T, Zhong T, Zhang M, Xu Y, Zhang M, Chen L |
International journal of molecular sciences | 2023 |
Endothelial Cell APOE3 Regulates Neurovascular, Neuronal, and Behavioral Function
Marottoli FM, Zhang H, Flores-Barrera E, Artur de la Villarmois E, Damen FC, Miguelez Fernández AM, Blesson HV, Chaudhary R, Nguyen AL, Nwokeji AE, Talati R, John AS, Madadakere K, Lutz SE, Cai K, Tseng KY, Tai LM |
Arteriosclerosis, thrombosis, and vascular biology | 2023 |
Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia
Poliakova T, Wellington CL |
Molecular Neurodegeneration | 2023 |
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck PJ, Morris JK, Stanford JA |
Degenerative Neurological and Neuromuscular Disease | 2023 |
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread
Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, Wang C, Park J, Travis Tabor G, Jiang H, Li K, Davis AA, Yuede CM, Colonna M, Ulrich JD, Holtzman DM |
Cell | 2023 |
Brain apolipoprotein E levels in mice challenged by a Western diet increase in an allele-dependent manner.
Liemisa B, Newbury SF, Novy MJ, Pasato JA, Morales-Corraliza J, Peng KY, Mathews PM |
2023 | |
Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models
Matsuo K, Nshihara H |
Neural Regeneration Research | 2023 |
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
F Vecchio, P Bisceglia, B Imbimbo, M Lozupone, R Latino, E Resta, M Leone, V Solfrizzi, A Greco, A Daniele, M Watling, F Panza, D Seripa |
Therapeutic Advances in Chronic Disease | 2022 |
Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites
Rhea EM, Banks WA, Raber J |
Biomedicines | 2022 |
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s Disease
Parhizkar S, Holtzman DM |
Seminars in Immunology | 2022 |
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Fernández-Calle R, Konings SC, Frontiñán-Rubio J, García-Revilla J, Camprubí-Ferrer L, Svensson M, Martinson I, Boza-Serrano A, Venero JL, Nielsen HM, Gouras GK, Deierborg T |
Molecular Neurodegeneration | 2022 |
APOE4 derived from astrocytes leads to blood-brain barrier impairment.
Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, Hyman BT |
Brain : a journal of neurology | 2022 |
Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice.
Giannisis A, Patra K, Edlund AK, Nieto LA, Benedicto-Gras J, Moussaud S, de la Rosa A, Twohig D, Bengtsson T, Fu Y, Bu G, Bial G, Foquet L, Hammarstedt C, Strom S, Kannisto K, Raber J, Ellis E, Nielsen HM |
Molecular Psychiatry | 2022 |
Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.
Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, Wang N, Martens YA, Qiao W, Wang M, Zhao N, Jia L, Yamazaki Y, Yamazaki A, Rosenberg CL, Wang Z, Kong D, Li Z, Kuchenbecker LA, Trottier ZA, Felton L, Rogers J, Quicksall ZS, Linares C, Knight J, Chen Y, Kurti A, Kanekiyo T, Fryer JD, Asmann YW, Storz P, Wang X, Peng J, Zhang B, Kim BYS, Bu G |
Nature Neuroscience | 2022 |
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
Giannisis A, Al-Grety A, Carlsson H, Patra K, Twohig D, Sando SB, Lauridsen C, Berge G, Grøntvedt GR, Bråthen G, White LR, Kultima K, Nielsen HM |
Alzheimer's research & therapy | 2022 |
Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome.
Zlatic SA, Duong D, Gadalla KKE, Murage B, Ping L, Shah R, Fink JJ, Khwaja O, Swanson LC, Sahin M, Rayaprolu S, Kumar P, Rangaraju S, Bird A, Tarquinio D, Carpenter R, Cobb S, Faundez V |
iScience | 2022 |
Liver-ing in your head rent free: peripheral ApoE4 drives CNS pathology.
Golden LR, Johnson LA |
Molecular Neurodegeneration | 2022 |
Prophylactic treatment with CN-105 improves functional outcomes in a murine model of closed head injury.
Van Wyck D, Kolls BJ, Wang H, Cantillana V, Maughan M, Laskowitz DT |
Experimental Brain Research | 2022 |
Lipoproteins in the Central Nervous System: From Biology to Pathobiology.
Raulin AC, Martens YA, Bu G |
Annual Review of Biochemistry | 2022 |
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC |
Molecular Neurodegeneration | 2022 |
Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise
Scarfò G, Piccarducci R, Daniele S, Franzoni F, Martini C |
Antioxidants | 2022 |
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
Brodeur MR, Rhainds D, Charpentier D, Boulé M, Mihalache-Avram T, Mecteau M, Brand G, Pedneault-Gagnon V, Fortier A, Niesor EJ, Rhéaume E, Maugeais C, Tardif JC |
Journal of lipid research | 2022 |
Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias.
Cooper O, Hallett P, Isacson O |
The FEBS journal | 2022 |
The small HDL particle hypothesis of Alzheimer’s disease
Martinez AE, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, Rees JC, Parks BA, Gardner MS, King SM, Collier TS, Harrington MG, Sweeney MD, Wang X, Zlokovic BV, Joe E, Nation DA, Schneider LS, Chui HC, Barr JR, Han SD, Krauss RM, Yassine HN |
Alzheimer's & dementia : the journal of the Alzheimer's Association | 2022 |
Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases
JV Valkenburgh, C Meuret, AE Martinez, V Kodancha, V Solomon, K Chen, HN Yassine |
Frontiers in physiology | 2021 |
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
A Serrano-Pozo, S Das, BT Hyman |
Lancet neurology | 2021 |
The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex
Y Liu, JH Song, W Xu, XH Hou, JQ Li, JT Yu, L Tan, S Chi |
Frontiers in neuroscience | 2021 |
APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention
X Zhou, AK Fu, NY Ip |
Current Opinion in Neurobiology | 2021 |
Apolipoprotein E derived from CD11c+ cells ameliorates atherosclerosis
Sauter M, Sauter RJ, Nording H, Lin C, Olbrich M, Autenrieth S, Gleissner C, Thunemann M, Otero N, Lutgens E, Aherrahrou Z, Wolf D, Zender L, Meuth S, Feil R, Langer HF |
iScience | 2021 |
The Role of ApoE Expression and Variability of Its Glycosylation in Human Reproductive Health in the Light of Current Information
M Kacperczyk, A Kmieciak, EM Kratz |
International journal of molecular sciences | 2021 |
Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier
EM Rhea, WA Banks |
Pharmaceutical Research | 2021 |
Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
AS Vallés, FJ Barrantes |
Frontiers in molecular neuroscience | 2021 |
Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
AK Edlund, K Chen, W Lee, H Protas, Y Su, E Reiman, R Caselli, HM Nielsen |
Journal of Alzheimer's disease : JAD | 2021 |
Is pseudoexfoliation glaucoma a neurodegenerative disorder?
B Padhy, DP Alone |
Journal of Biosciences | 2021 |
Hypothesis: Entrapment of lipoprotein particles in the brain causes Alzheimer's disease.
Boche D, Nicoll JA |
Free neuropathology | 2021 |
ApoE mimetic improves pathology and memory in a model of Alzheimer’s disease
K Krishnamurthy, V Cantillana, H Wang, PM Sullivan, BJ Kolls, X Ge, Y Lin, B Mace, DT Laskowitz |
Brain Research | 2020 |
Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells
O Kalchiem-Dekel, X Yao, AV Barochia, M Kaler, DM Figueroa, WB Karkowsky, EM Gordon, M Gao, MM Fergusson, X Qu, P Liu, Y Li, F Seifuddin, M Pirooznia, SJ Levine |
American journal of respiratory cell and molecular biology | 2020 |
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Z Li, F Shue, N Zhao, M Shinohara, G Bu |
Molecular Neurodegeneration | 2020 |
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
T Williams, DR Borchelt, P Chakrabarty |
Molecular Neurodegeneration | 2020 |
Transendothelial transport of lipoproteins
E Jang, J Robert, L Rohrer, A von Eckardstein, WL Lee |
Atherosclerosis | 2020 |
Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review
JC Nascimento, GA Matos, LC Pereira, AE Mourão, AM Sampaio, RB Oriá, P Toniutto |
ANN HEPATOL | 2020 |
The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
D Chernick, R Zhong, L Li |
Biomolecules | 2020 |
Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia
M Koch, ST DeKosky, M Goodman, J Sun, JD Furtado, AL Fitzpatrick, RH Mackey, T Cai, OL Lopez, LH Kuller, KJ Mukamal, MK Jensen |
2020 | |
Sphingolipids in Alzheimer's disease, how can we target them?
SM Crivelli, C Giovagnoni, L Visseren, AL Scheithauer, N de Wit, S den Hoedt, M Losen, MT Mulder, J Walter, HE de Vries, E Bieberich, P Martinez-Martinez |
Advanced Drug Delivery Reviews | 2020 |
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
J Robert, EB Button, EM Martin, L McAlary, Z Gidden, M Gilmour, G Boyce, TM Caffrey, A Agbay, A Clark, JM Silverman, NR Cashman, CL Wellington |
Molecular Neurodegeneration | 2020 |
Pulsed SILAM Reveals In Vivo Dynamics of Murine Brain Protein Translation
SS Ng, JE Park, W Meng, CP Chen, RN Kalaria, NE McCarthy, SK Sze |
ACS Omega | 2020 |
Beyond the CNS: The many peripheral roles of APOE
AB Martinez-Martínez, E Torres-Perez, N Devanney, RD Moral, LA Johnson, JM Arbones-Mainar |
Neurobiology of Disease | 2020 |
Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury
ML James, JM Komisarow, H Wang, DT Laskowitz |
Neurotherapeutics | 2020 |
An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
J Robert, NL Weilinger, LP Cao, S Cataldi, EB Button, S Stukas, EM Martin, P Seibler, M Gilmour, TM Caffrey, EM Rowe, J Fan, B MacVicar, MJ Farrer, CL Wellington |
Molecular Neurodegeneration | 2020 |
Validation of a novel and accurate ApoE4 assay for automated chemistry analyzers
S Veiga, A Rodríguez-Martín, G Garcia-Ribas, I Arribas, M Menacho-Román, M Calero |
Scientific Reports | 2020 |
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease
S Pedrini, P Chatterjee, E Hone, RN Martins |
Journal of Neurochemistry | 2020 |
Tau Biology
A Takashima, B Wolozin, L Buee |
2019 | |
Tau Biology
A Takashima, B Wolozin, L Buee |
2019 | |
Peripheral versus central nervous system APOE in Alzheimer’s disease: Interplay across the blood-brain barrier
D Chernick, S Ortiz-Valle, A Jeong, W Qu, L Li |
Neuroscience Letters | 2019 |
Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease
U Jin, SJ Park, SM Park |
Experimental Neurobiology | 2019 |
Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
KL Rasmussen, A Tybjærg-Hansen, BG Nordestgaard, R Frikke-Schmidt |
European Heart Journal | 2019 |
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius |
Neuron | 2019 |
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells
CS Baaklini, KS Rawji, GJ Duncan, MF Ho, JR Plemel |
Frontiers in molecular neuroscience | 2019 |
Neurodegeneration and Alzheimer's Disease: The Role of Diabetes, Genetics, Hormones, and Lifestyle
RN Martins, CS Brennan, WM Fernando, MA Brennan, SJ Fuller |
2019 | |
Lipid-Binding Proteins in Brain Health and Disease
M Corraliza-Gomez, D Sanchez, MD Ganfornina |
Frontiers in neurology | 2019 |
Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation
A Hatziri, C Kalogeropoulou, E Xepapadaki, E Birli, EA Karavia, E Papakosta, S Filou, C Constantinou, KE Kypreos |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 |
Apolipoproteins and Alzheimer's pathophysiology
M Koch, ST DeKosky, AL Fitzpatrick, JD Furtado, OL Lopez, LH Kuller, RH Mackey, TM Hughes, KJ Mukamal, MK Jensen |
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2018 |
Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury
X Cheng, Y Zheng, P Bu, X Qi, C Fan, F Li, DH Kim, Q Cao |
Experimental Neurology | 2018 |
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
KL Rasmussen, A Tybjærg-Hansen, BG Nordestgaard, R Frikke-Schmidt |
Alzheimer's & dementia : the journal of the Alzheimer's Association | 2018 |
High-Density Lipoprotein Subclasses and Mild Cognitive Impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia) 1
R Ohtani, S Nirengi, M Nakamura, N Murase, M Sainouchi, Y Kuwata, M Takata, Y Masuda, K Kotani, N Sakane |
Journal of Alzheimer's disease : JAD | 2018 |
Apolipoprotein E, Receptors and Modulation of Alzheimer’s Disease
N Zhao, CC Liu, W Qiao, G Bu |
Biological Psychiatry | 2017 |
Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease: Theme: Drug Discovery, Development and Delivery in Alzheimer’s Disease Guest Editor: Davide Brambilla
SE Storck, CU Pietrzik |
Pharmaceutical Research | 2017 |
Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism
KD Bruce, A Zsombok, RH Eckel |
Frontiers in Endocrinology | 2017 |
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception
Kyriakos E Kypreos, Eleni A Karavia, Caterina Constantinou, Aikaterini Hatziri, Christina Kalogeropoulou, Eva Xepapadaki, Evangelia Zvintzou |
Journal of Biomedical Research | 2017 |
Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model
DT Laskowitz, H Wang, T Chen, DT Lubkin, V Cantillana, TM Tu, D Kernagis, G Zhou, G Macy, BJ Kolls, HN Dawson |
Scientific Reports | 2017 |
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease
P Johansson, EG Almqvist, M Bjerke, A Wallin, JO Johansson, U Andreasson, K Blennow, H Zetterberg, J Svensson |
Journal of Alzheimer's disease : JAD | 2017 |
Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma
M Koch, JD Furtado, K Falk, F Leypoldt, KJ Mukamal, MK Jensen |
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2017 |
Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma
AT Baker-Nigh, KG Mawuenyega, JG Bollinger, V Ovod, T Kasten, EE Franklin, F Liao, H Jiang, D Holtzman, NJ Cairns, JC Morris, RJ Bateman |
The Journal of biological chemistry | 2016 |
Central Nervous System LipoproteinsHighlights: ApoE and Regulation of Cholesterol Metabolism
RW Mahley |
Arteriosclerosis, thrombosis, and vascular biology | 2016 |
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
RW Mahley |
Journal of Molecular Medicine | 2016 |
Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation
TM Achariyar, B Li, W Peng, PB Verghese, Y Shi, E McConnell, A Benraiss, T Kasper, W Song, T Takano, DM Holtzman, M Nedergaard, R Deane |
Molecular Neurodegeneration | 2016 |
Plasma apolipoprotein E and severity of suicidal behaviour
P Asellus, P Nordström, AL Nordström, J Jokinen |
Journal of Affective Disorders | 2016 |
Developing Therapeutics for Alzheimer's Disease
H Zetterberg, K Blennow |
Developing Therapeutics for Alzheimer's Disease | 2016 |
Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review
KL Rasmussen |
Atherosclerosis | 2016 |
Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
A Boehm-Cagan, R Bar, D Harats, A Shaish, H Levkovitz, JK Bielicki, JO Johansson, DM Michaelson, MK Lakshmana |
PloS one | 2016 |
Advances in high-density lipoprotein physiology: surprises, overturns, and promises
C Constantinou, EA Karavia, E Xepapadaki, PI Petropoulou, E Papakosta, M Karavyraki, E Zvintzou, V Theodoropoulos, S Filou, A Hatziri, C Kalogeropoulou, G Panayiotakopoulos, KE Kypreos |
American journal of physiology. Endocrinology and metabolism | 2016 |
Plasma levels of apolipoprotein E and risk of dementia in the general population: Plasma apoE and Dementia
KL Rasmussen, A Tybjaerg-Hansen, BG Nordestgaard, R Frikke-Schmidt |
Annals of Neurology | 2015 |
Apolipoprotein E levels and Alzheimer risk: ApoE Levels and Alzheimer Risk
BT Hyman, DM Holtzman |
Annals of Neurology | 2015 |
APOE -modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data and future perspective
LM Tai, S Ghura, KP Koster, V Liakaite, M Maienschein-Cline, P Kanabar, N Collins, M Ben-Aissa, AZ Lei, N Bahroos, S Green, B Hendrickson, LJ van Eldik, MJ LaDu |
Journal of Neurochemistry | 2015 |
Cholesterol metabolism and homeostasis in the brain
J Zhang, Q Liu |
Protein & Cell | 2015 |
Biochemical properties in membrane of rat astrocytes under oxidative stress
J Ito, Y Nagayasu, T Ogawa, H Okihara, M Michikawa |
Brain Research | 2015 |
Cholesterol in myelin biogenesis and hypomyelinating disorders
G Saher, SK Stumpf |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2015 |
High-density lipoproteins at the interface between central nervous system and plasma lipoprotein metabolism
J Robert, WH Cheng, A Hayat, T Ward-Able, CL Wellington |
Clinical Lipidology | 2015 |
Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats
KL Pepple, L Rotkis, L Wilson, A Sandt, RN van Gelder |
Investigative ophthalmology & visual science | 2015 |
Plasma biomarkers for neuronal ceroid lipofuscinosis
SL Hersrud, RD Geraets, KL Weber, CH Chan, DA Pearce |
FEBS Journal | 2015 |
Apolipoprotein Mimetics in the Management of Human Disease
GM Anantharamaiah, D Goldberg |
2015 | |
HDL and cognition in neurodegenerative disorders
DA Hottman, D Chernick, S Cheng, Z Wang, L Li |
Neurobiology of Disease | 2014 |
Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
M Lefèvre, DJ Felmlee, M Parnot, TF Baumert, C Schuster |
PloS one | 2014 |
ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro
E Nwabuisi‑Heath, GW Rebeck, MJ LaDu, C Yu |
ASN NEURO | 2014 |
ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes
J Ito, M Michikawa |
Journal of Lipids | 2014 |
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice
H Tavori, D Fan, I Giunzioni, L Zhu, MF Linton, AB Fogo, S Fazio |
Journal of lipid research | 2014 |
Development and partial characterisation of an antiserum against apolipoprotein B of the short-finned eel, Anguilla australis
EL Damsteegt, H Mizuta, Y Ozaki, N Hiramatsu, T Todo, A Hara, S Ijiri, S Adachi, PM Lokman |
Journal of Comparative Physiology B | 2014 |
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
E Martínez-Morillo, O Hansson, Y Atagi, G Bu, L Minthon, EP Diamandis, HM Nielsen |
Acta Neuropathologica | 2014 |
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
S Stukas, J Robert, CL Wellington |
Cell Metabolism | 2014 |
Increasing cellular level of phosphatidic acid enhances FGF-1 production in long term-cultured rat astrocytes
Y Nagayasu, S Morita, H Hayashi, Y Miura, K Yokoyama, M Michikawa, J Ito |
Brain Research | 2014 |
Astrocyte׳s endogenous apoE generates HDL-like lipoproteins using previously synthesized cholesterol through interaction with ABCA1
J Ito, Y Nagayasu, Y Miura, S Yokoyama, M Michikawa |
Brain Research | 2014 |
HDL and cholesterol handling in the brain
C Vitali, CL Wellington, L Calabresi |
Cardiovascular Research | 2014 |
Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
M Lefèvre, DJ Felmlee, M Parnot, TF Baumert, C Schuster, R Ray |
PloS one | 2014 |
Hormonal modulators of glial ABCA1 and apoE levels
J Fan, Y Shimizu, J Chan, A Wilkinson, A Ito, P Tontonoz, E Dullaghan, LA Galea, T Pfeifer, CL Wellington |
Journal of lipid research | 2013 |
Links between copper and cholesterol in Alzheimer's disease
YH Hung, AI Bush, SL Fontaine |
Frontiers in physiology | 2013 |
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease
RE Kennedy, GR Cutter, LS Schneider |
Alzheimer's and Dementia | 2013 |
ApolipoproteinE mimetic peptides improve outcome after focal ischemia
H Wang, LG Anderson, CD Lascola, ML James, TN Venkatraman, ER Bennett, SK Acheson, MP Vitek, DT Laskowitz |
Experimental Neurology | 2013 |
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis
J Wei, M Zheng, P Liang, Y Wei, X Yin, Y Tang, Y Xue |
Neurobiology of Disease | 2013 |
Enhancement of FGF-1 release along with cytosolic proteins from rat astrocytes by hydrogen peroxide
J Ito, Y Nagayasu, M Hoshikawa, KH kato, Y Miura, K Asai, H Hayashi, S Yokoyama, M Michikawa |
Brain Research | 2013 |
Serum Apolipoprotein E as a Marker to Monitor Graft Function After Hepatocyte Transplantation in a Clinically Relevant Mouse Model
C Jorns, T Takahashi, E Callaghan, H Zemack, L Larsson, G Nowak, P Parini, BG Ericzon, E Ellis |
Transplantation Proceedings | 2013 |
ApoE and outcome after traumatic brain injury
S Gokhale, DT Laskowitz |
Clinical Lipidology | 2013 |
Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer’s Disease
RJ Kandimalla, WY Wani, R Anand, A Kaushal, S Prabhakar, VK Grover, N Bharadwaj, K Jain, KD Gill |
American journal of Alzheimer's disease and other dementias | 2013 |
Genetic Variants in Alzheimer's Disease
K Morgan, MM Carrasquillo |
2013 | |
Cholesterol: Its Regulation and Role in Central Nervous System Disorders
M Orth, S Bellosta |
Cholesterol | 2012 |
Potential biomarkers in psychiatry: focus on the cholesterol system
AG Woods, I Sokolowska, R Taurines, M Gerlach, E Dudley, J Thome, CC Darie |
Journal of Cellular and Molecular Medicine | 2012 |
In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
KR Wildsmith, JM Basak, BW Patterson, Y Pyatkivskyy, J Kim, KE Yarasheski, JX Wang, KG Mawuenyega, H Jiang, M Parsadanian, H Yoon, T Kasten, WC Sigurdson, C Xiong, A Goate, DM Holtzman, RJ Bateman |
PloS one | 2012 |
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
C Cruchaga, JS Kauwe, P Nowotny, K Bales, EH Pickering, K Mayo, S Bertelsen, A Hinrichs, AM Fagan, DM Holtzman, JC Morris, AM Goate |
Human Molecular Genetics | 2012 |
Administration of COG1410 Reduces Axonal Amyloid Precursor Protein Immunoreactivity and Microglial Activation after Controlled Cortical Impact in Mice
Y Jiang, DL Brody |
Journal of Neurotrauma | 2012 |
Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
E Cudaback, X Li, Y Yang, T Yoo, KS Montine, S Craft, TJ Montine, CD Keene |
Journal of Neuroinflammation | 2012 |
In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
KR Wildsmith, JM Basak, BW Patterson, Y Pyatkivskyy, J Kim, KE Yarasheski, JX Wang, KG Mawuenyega, H Jiang, M Parsadanian, H Yoon, T Kasten, WC Sigurdson, C Xiong, A Goate, DM Holtzman, RJ Bateman, S Estus |
PloS one | 2012 |
Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice
N Gaudreault, N Kumar, VR Olivas, D Eberlé, JH Rapp, RL Raffai, M Lisanti |
PloS one | 2012 |
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo
N Luo, X Wang, BH Chung, MH Lee, RL Klein, WT Garvey, Y Fu |
American journal of physiology. Endocrinology and metabolism | 2011 |
ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase Cγ in rat astrocytes
J Ito, Y Nagayasu, A Kheirollah, S Abe-Dohmae, S Yokoyama |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2011 |
An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia
J Fan, S Stukas, C Wong, J Chan, S May, N DeValle, V Hirsch-Reinshagen, A Wilkinson, MN Oda, CL Wellington |
Journal of lipid research | 2011 |
Apolipoprotein E: from lipid transport to neurobiology
PS Hauser, V Narayanaswami, RO Ryan |
Progress in Lipid Research | 2011 |
Cholesterol metabolism in neurons and astrocytes
FW Pfrieger, N Ungerer |
Progress in Lipid Research | 2011 |
Lipid metabolism in the central nervous system and neurodegenerative diseases
H Hayashi |
Folia Pharmacologica Japonica | 2011 |
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
H Hayashi |
Biological & Pharmaceutical Bulletin | 2011 |
The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1
S Stukas, S May, A Wilkinson, J Chan, J Donkin, CL Wellington |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2011 |
An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia
J Fan, S Stukas, C Wong, J Chan, S May, N DeValle, V Hirsch-Reinshagen, A Wilkinson, MN Oda, CL Wellington |
Journal of lipid research | 2011 |
Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors
J Brodbeck, J McGuire, Z Liu, A Meyer-Franke, ME Balestra, D Jeong, M Pleiss, C McComas, F Hess, D Witter, S Peterson, M Childers, M Goulet, N Liverton, R Hargreaves, S Freedman, KH Weisgraber, RW Mahley, Y Huang |
The Journal of biological chemistry | 2011 |
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo
N Luo, X Wang, BH Chung, MH Lee, RL Klein, WT Garvey, Y Fu |
American journal of physiology. Endocrinology and metabolism | 2011 |
Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis
RM Uranga, JN Keller |
Current Gerontology and Geriatrics Research | 2010 |
Apolipoproteins in the brain: implications for neurological and psychiatric disorders
DA Elliott, CS Weickert, B Garner |
Clinical Lipidology | 2010 |
Traumatic Brain Injury Exacerbates Neurodegenerative Pathology: Improvement with an Apolipoprotein E-Based Therapeutic
DT Laskowitz, P Song, H Wang, B Mace, PM Sullivan, MP Vitek, HN Dawson |
Journal of Neurotrauma | 2010 |
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis
H Zhang, J Wu, J Zhu |
Journal of biomedicine & biotechnology | 2010 |
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis
HL Zhang, J Wu, J Zhu |
Clinical & developmental immunology | 2010 |
Comment on: Cerebrospinal fluid apolipoprotein E concentration decreases after seizure
J Wu, P Liu, J Lei, HL Zhang |
Seizure | 2010 |
Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid
P Khumsupan, R Ramirez, D Khumsupan, V Narayanaswami |
Biochimica et Biophysica Acta | 2010 |
COG1410, an Apolipoprotein E-based Peptide, Improves Cognitive Performance and Reduces Cortical Loss Following Moderate Fluid Percussion Injury in the Rat
NA Kaufman, JE Beare, AA Tan, MP Vitek, SE McKenna, MR Hoane |
Behavioural Brain Research | 2010 |
Lipoprotein remodelling in the periphery: A model for the brain?
C Yu, KL Youmans, MJ LaDu |
Biochimica et Biophysica Acta | 2010 |
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
MR Farlow |
Alzheimer's research & therapy | 2010 |
Novel Genetic Mutation in Apolipoprotein E2 Homozygosis and Its Implication in Organ Donation: A Case Report
N Cautero, FD Benedetto, ND Ruvo, R Montalti, GP Guerrini, R Ballarin, M Spaggiari, N Smerieri, MG Blasiis, G Rompianesi, RM Iemmolo, M Marino, M Bertolotti, S Zivieri, GE Gerunda |
Transplantation Proceedings | 2010 |
Pyrene Fluorescence Analysis Offers New Insights into the Conformation of the Lipoprotein-Binding Domain of Human Apolipoprotein E
AB Patel, P Khumsupan, V Narayanaswami |
Biochemistry | 2010 |
Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo
ZH Huang, D Gu, T Mazzone |
American journal of physiology. Endocrinology and metabolism | 2009 |
APOEmRNA and protein expression in postmortem brain are modulated by an extended haplotype structure
LM Bekris, NM Galloway, TJ Montine, GD Schellenberg, CE Yu |
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | 2009 |
COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia
EA Tukhovskaya, AY Yukin, ON Khokhlova, AN Murashev, MP Vitek |
Journal of Neuroscience Research | 2009 |
COG1410 Improves Cognitive Performance and Reduces Cortical Neuronal Loss in the Traumatically Injured Brain
MR Hoane, N Kaufman, MP Vitek, SE McKenna |
Journal of Neurotrauma | 2009 |
Cholesterol metabolism and transport in the pathogenesis of Alzheimerâs disease
IJ Martins, T Berger, MJ Sharman, G Verdile, SJ Fuller, RN Martins |
Journal of Neurochemistry | 2009 |
Differential effects of simvastatin and pravastatin on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells
W Dong, S Vuletic, JJ Albers |
Journal of lipid research | 2009 |
Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo
ZH Huang, DS Gu, T Mazzone |
American journal of physiology. Endocrinology and metabolism | 2009 |
Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage
ML James, PM Sullivan, CD Lascola, MP Vitek, DT Laskowitz |
Stroke; a journal of cerebral circulation | 2009 |
Apolipoprotein E isoform-specific disruption of Alzheimer's amyloid beta-peptide clearance from brain
Rashid Deane, Abhay Sagare, Katie Hamm, Margaret Parisi, Steven Lane, Mary Beth Finn, David M. Holtzman, Berislav V. Zlokovic |
Journal of Clinical Investigation | 2008 |
Apolipoprotein E and cholesterol in aging and disease in the brain
EP de Chaves, V Narayanaswami |
Future Lipidology | 2008 |
Multiple SNPs Within and Surrounding the Apolipoprotein E Gene Influence Cerebrospinal Fluid Apolipoprotein E Protein Levels
LM Bekris, SP Millard, NM Galloway, S Vuletic, JJ Albers, G Li, DR Galasko, C DeCarli, MR Farlow, CM Clark, JF Quinn, JA Kaye, GD Schellenberg, D Tsuang, ER Peskind, CE Yu |
Journal of Alzheimer's disease : JAD | 2008 |
Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice
RD Atkinson, KR Coenen, MR Plummer, ML Gruen, AH Hasty |
American journal of physiology. Endocrinology and metabolism | 2008 |
Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects
T Miida, A Takahashi, T Ikeuchi |
Pharmacology & Therapeutics | 2007 |
Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions
DT Laskowitz, MP Vitek |
Pharmacogenomics | 2007 |
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer’s disease pathology following closed head injury: Evidence of pharmacogenomic interaction
H Wang, L Durham, H Dawson, P Song, DS Warner, PM Sullivan, MP Vitek, DT Laskowitz |
Neuroscience | 2007 |
COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury
DT Laskowitz, SE McKenna, P Song, H Wang, L Durham, N Yeung, D Christensen, MP Vitek |
Journal of Neurotrauma | 2007 |
Impaired Secretion of Apolipoprotein E2 from Macrophages
D Fan, S Qiu, CD Overton, PG Yancey, LL Swift, WG Jerome, MR Linton, S Fazio |
The Journal of biological chemistry | 2007 |
Assessment of Nutritional Status and Prediction of Postoperative Liver Function from Serum Apolioprotein A-1 Levels with Hepatectomy
T Katsuramaki, T Mizuguchi, M Kawamoto, K Yamaguchi, M Meguro, M Nagayama, T Nobuoka, Y Kimura, T Furuhata, K Hirata |
World Journal of Surgery | 2006 |
Genetic Factors in Outcome After Traumatic Brain Injury
R Diaz-Arrastia, VK Baxter |
Journal of Head Trauma Rehabilitation | 2006 |
Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function
M Michikawa |
Acta Neurologica Scandinavica | 2006 |
Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease
DT Laskowitz, H Fillit, N Yeung, K Toku, MP Vitek |
Acta Neurologica Scandinavica | 2006 |
A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage
J Gao, H Wang, H Sheng, JR Lynch, DS Warner, L Durham, MP Vitek, DT Laskowitz |
Neurocritical Care | 2006 |
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury
JR Lynch, H Wang, B Mace, S Leinenweber, DS Warner, ER Bennett, MP Vitek, S McKenna, DT Laskowitz |
Experimental Neurology | 2005 |
Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic–ischemic injury
J Mcadoo, D Warner, R Goldberg, M Vitek, R Pearlstein, D Laskowitz |
Neuroscience Letters | 2005 |
The Blood-Brain Barrier and Its Microenvironment: Basic Physiology to Neurological Disease
H Wolburg, A Warth |
The Blood-Brain Barrier and Its Microenvironment: Basic Physiology to Neurological Disease | 2005 |
Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action
J Ito, Y Nagayasu, R Lu, A Kheirollah, M Hayashi, S Yokoyama |
Journal of lipid research | 2005 |
Generation and function of astroglial lipoproteins from Niemann–Pick type C1-deficient mice
B KARTEN, H HAYASHI, GA FRANCIS, RB CAMPENOT, DE VANCE, JE VANCE |
Biochemical Journal | 2005 |
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta
M Morikawa, JD Fryer, PM Sullivan, EA Christopher, SE Wahrle, RB DeMattos, MA O'Dell, AM Fagan, HA Lashuel, T Walz, K Asai, DM Holtzman |
Neurobiology of Disease | 2004 |
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes
Y Liang, S Lin, TP Beyer, Y Zhang, X Wu, KR Bales, RB DeMattos, PC May, SD Li, XC Jiang, PI Eacho, G Cao, SM Paul |
Journal of Neurochemistry | 2004 |
Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism
CL Wellington |
Clinical Genetics | 2004 |
Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity
I Maezawa, LW Jin, RL Woltjer, N Maeda, GM Martin, TJ Montine, KS Montine |
Journal of Neurochemistry | 2004 |
ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis
AM Fagan, E Christopher, JW Taylor, M Parsadanian, M Spinner, M Watson, JD Fryer, S Wahrle, KR Bales, SM Paul, DM Holtzman |
The American Journal of Pathology | 2004 |
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
AM Fagan, E Christopher, JW Taylor, M Parsadanian, M Spinner, M Watson, JD Fryer, S Wahrle, KR Bales, SM Paul, DM Holtzman |
The American Journal of Pathology | 2004 |
Identification of a novel enhancer of brain expression near the apoE gene cluster by comparative genomics
Ping Zheng, Len A Pennacchio, Wilfried Le Goff, Edward M Rubin, Jonathan D Smith |
Biochimica et Biophysica Acta | 2004 |
Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain
V Hirsch-Reinshagen, S Zhou, BL Burgess, L Bernier, SA McIsaac, JY Chan, GH Tansley, JS Cohn, MR Hayden, CL Wellington |
The Journal of biological chemistry | 2004 |
ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE
SE Wahrle, H Jiang, M Parsadanian, J Legleiter, X Han, JD Fryer, T Kowalewski, DM Holtzman |
The Journal of biological chemistry | 2004 |
Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis
L Táborský, P Adam, O Sobek, M Dostál, J Dvořáková, L Dubská |
Folia Microbiologica | 2003 |
Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage
AD Kay, SP Day, JA Nicoll, CJ Packard, MJ Caslake |
Atherosclerosis | 2003 |
Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE
D Peng, C Song, CA Reardon, S Liao, GS Getz |
Journal of Neurochemistry | 2003 |
Cerebrospinal Fluid Apolipoprotein E Concentration Decreases after Traumatic Brain Injury
AD Kay, A Petzold, M Kerr, G Keir, EJ Thompson, JA Nicoll |
Journal of Neurotrauma | 2003 |
Remodeling of Cerebrospinal Fluid Lipoprotein Particles after Human Traumatic Brain Injury
AD Kay, SP Day, M Kerr, JA Nicoll, CJ Packard, MJ Caslake |
Journal of Neurotrauma | 2003 |
Alzheimer’s Disease
DS Vohora, LC Mishra |
Scientific Basis for Ayurvedic Therapies | 2003 |
Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease
S Vuletic, LW Jin, SM Marcovina, ER Peskind, T Möller, JJ Albers |
Journal of lipid research | 2003 |
Cholesterol: from heart attacks to Alzheimer's disease
RL Raffaï, KH Weisgraber |
Journal of lipid research | 2003 |
APOE ε3/ε4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer’s disease diagnosis
H Fukumoto, M Ingelsson, N Gårevik, LO Wahlund, N Nukina, Y Yaguchi, M Shibata, BT Hyman, GW Rebeck, MC Irizarry |
Experimental Neurology | 2003 |
Differential metabolism of ApoE isoforms in plasma and CSF
SE Wahrle, DM Holtzman |
Experimental Neurology | 2003 |
Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy
T Katsuramaki, K Hirata, Y Kimura, M Nagayama, M Meguro, H Kimura, T Honma, T Furuhata, U Hideki, F Hata, M Mukaiya |
Wound Repair and Regeneration | 2002 |
Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E
Y Sakai, DK Kim, S Iwasa, J Liang, T Watanabe, M Onodera, H Nakauchi |
Atherosclerosis | 2002 |
Apolipoproteins and aging: emerging mechanisms
JD Smith |
Ageing Research Reviews | 2002 |
Apolipoproteins and ? Amyloid Transport Pathway
K Kamino, T Kida, T Tanaka, H Tanii, M Okochi, T Kudo, T Kobayashi, M Takeda |
Psychogeriatrics | 2002 |
Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes
K Bach-Ngohou, K Ouguerram, H Nazih, P Maugère, B Ripolles-Piquer, Y Zaïr, R Frénais, M Krempf, JM Bard |
International Journal of Obesity | 2002 |
Hypomorphic Apolipoprotein E Mice: A NEW MODEL OF CONDITIONAL GENE REPAIR TO EXAMINE APOLIPOPROTEIN E-MEDIATED METABOLISM
RL Raffaı̈, KH Weisgraber |
The Journal of biological chemistry | 2002 |
Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
J Kovar, RJ Havel |
Journal of lipid research | 2002 |
Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons
B Karten, DE Vance, RB Campenot, JE Vance |
The Journal of biological chemistry | 2002 |
Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.
Holtzman DM |
Journal of molecular neuroscience : MN | 2001 |
Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice
RB DeMattos, RP Brendza, JE Heuser, M Kierson, JR Cirrito, J Fryer, PM Sullivan, AM Fagan, X Han, DM Holtzman |
Neurochemistry International | 2001 |
Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice
A Auger, TQ Truong, D Rhainds, J Lapointe, F Letarte, L Brissette |
European Journal of Biochemistry | 2001 |
Expression of the Apolipoprotein E Gene in the Skin is Controlled by a Unique Downstream Enhancer
S Grehan, C Allan, E Tse, D Walker, JM Taylor |
Journal of Investigative Dermatology | 2001 |
Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2
F Brahimi, P Bertrand, M Starck, MM Galteau, G Siest |
Cell Biochemistry and Function | 2001 |
Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments
J Levin-Allerhand, BS McEwen, CE Lominska, DB Lubahn, KS Korach, JD Smith |
Journal of Neurochemistry | 2001 |
Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response
JR Lynch, D Morgan, J Mance, WD Matthew, DT Laskowitz |
Journal of Neuroimmunology | 2001 |
Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides
DT Laskowitz, AD Thekdi, SD Thekdi, SK Han, JK Myers, SV Pizzo, ER Bennett |
Experimental Neurology | 2001 |
Brain Injury
RS Clark, P Kochanek |
Brain Injury | 2001 |
Characterization of four lipoprotein classes in human cerebrospinal fluid
S Koch, N Donarski, K Goetze, M Kreckel, HJ Stuerenburg, C Buhmann, U Beisiegel |
Journal of lipid research | 2001 |
Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-? deposition in vivo
AM Fagan, DM Holtzman |
Microscopy Research and Technique | 2000 |
Lipoproteins in the Central Nervous System
MJ Ladu, C Reardon, LV Eldik, AM Fagan, G Bu, D Holtzman, GS Getz |
Annals of the New York Academy of Sciences | 2000 |
Intraventricular Infusion of Apolipoprotein E Ameliorates Acute Neuronal Damage After Global Cerebral Ischemia in Mice
K Horsburgh, J McCulloch, M Nilsen, E McCracken, C Large, AD Roses, JA Nicoll |
Journal of Cerebral Blood Flow and Metabolism | 2000 |
Differences in the A?40/A?42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
AM Fagan, LH Younkin, JC Morris, JD Fryer, TG Cole, SG Younkin, DM Holtzman |
Annals of Neurology | 2000 |
The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models
K Horsburgh, MO McCarron, F White, JA Nicoll |
Neurobiology of Aging | 2000 |
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection
A M Saunders, M K Trowers, R A Shimkets, S Blakemore, D J Crowther, T A Mansfield, D M Wallace, W J Strittmatter, A D Roses |
Biochimica et Biophysica Acta | 2000 |
Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses
AM Saunders |
Journal of Neuropathology and Experimental Neurology | 2000 |
Duplicated Downstream Enhancers Control Expression of the Human Apolipoprotein E Gene in Macrophages and Adipose Tissue
SJ Shih, C Allan, S Grehan, E Tse, C Moran, JM Taylor |
The Journal of biological chemistry | 2000 |
Effect of Macrophage-Derived Apolipoprotein E on Established Atherosclerosis in Apolipoprotein E–Deficient Mice
W Shi, X Wang, NJ Wang, WH McBride, AJ Lusis |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Low- and High-Density Lipoprotein Metabolism in HepG2 Cells Expressing Various Levels of Apolipoprotein E
D Charpentier, C Tremblay, E Rassart, D Rhainds, A Auger, RW Milne, L Brissette |
Biochemistry | 2000 |
Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
DM Holtzman, KR Bales, S Wu, P Bhat, M Parsadanian, AM Fagan, LK Chang, Y Sun, SM Paul |
Journal of Clinical Investigation | 1999 |
Macrophages, lipoprotein metabolism, and atherosclerosis
MR Linton, S Fazio |
Current Opinion in Lipidology | 1999 |
Epidermal expression of apolipoprotein E gene during fin and scale development and fin regeneration in zebrafish
MJ Monnot, PJ Babin, G Poleo, M Andre, L Laforest, C Ballagny, MA Akimenko |
Developmental Dynamics | 1999 |
Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent
U Beffert, JS Cohn, C Petit-Turcotte, M Tremblay, N Aumont, C Ramassamy, J Davignon, J Poirier |
Brain Research | 1999 |
Differential Generation of High-Density Lipoprotein by Endogenous and Exogenous Apolipoproteins in Cultured Fetal Rat Astrocytes
J Ito, LY Zhang, M Asai, S Yokoyama |
Journal of Neurochemistry | 1999 |
Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies
MR Linton, S Fazio |
Current Opinion in Lipidology | 1999 |
Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice
PT Xu, D Schmechel, HL Qiu, M Herbstreith, T Rothrock-Christian, M Eyster, AD Roses, JR Gilbert |
Neurobiology of Disease | 1999 |
Retroviral Gene Therapy in ApoE-Deficient Mice: ApoE Expression in the Artery Wall Reduces Early Foam Cell Lesion Formation
AH Hasty, MR Linton, SJ Brandt, VR Babaev, LA Gleaves, S Fazio |
Circulation | 1999 |
Mouse Models in the Study of Genetic Neurological Disorders
B Popko |
1999 | |
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration
M Buttini, M Orth, S Bellosta, H Akeefe, R E Pitas, T Wyss-Coray, L Mucke, R W Mahley |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 1999 |
Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E
K Yamauchi, M Tozuka, H Hidaka, E Hidaka, Y Kondo, T Katsuyama |
Clinical chemistry | 1999 |
Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice
WA Boisvert, LK Curtiss |
Journal of lipid research | 1999 |
Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration
Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW |
Journal of Neuroscience | 1999 |
Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma
J Fan, ZS Ji, Y Huang, H Silva, D Sanan, RW Mahley, TL Innerarity, JM Taylor |
Journal of Clinical Investigation | 1998 |
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor
MF Linton, AH Hasty, VR Babaev, S Fazio |
Journal of Clinical Investigation | 1998 |
Human apolipoprotein E allele-specific brain expressing transgenic mice
JD Smith, J Sikes, JA Levin |
Neurobiology of Aging | 1998 |
Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice
AD Roses, J Gilbert, PT Xu, P Sullivan, B Popko, DS Burkhart, T Christian-Rothrock, AM Saunders, N Maeda, DE Schmechel |
Neurobiology of Aging | 1998 |
Apolipoprotein E and ALzheimer's Disease: The Tip of the Susceptibility Iceberg
AD Roses |
Annals of the New York Academy of Sciences | 1998 |
Proposal of a multicompartmental model for use in the study of apolipoprotein E metabolism
JS Millar, AH Lichtenstein, GG Dolnikowski, JM Ordovas, EJ Schaefer |
Metabolism | 1998 |
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
A Slooter |
Neuroscience Letters | 1998 |
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
D Games, D Adams, R Alessandrini, R Barbour, P Berthelette, C Blackwell, T Carr, J Clemens, T Donaldson, F Gillespie |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 1998 |
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
D Games, D Adams, R Alessandrini, R Barbour, P Berthelette, C Blackwell, T Carr, J Clemens, T Donaldson, F Gillespie |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 1998 |
Liver Transplant Pathology in Pediatric Metabolic Disorders
R Jaffe |
Pediatric and Developmental Pathology | 1998 |
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins
KS Montine, CN Bassett, JJ Ou, WR Markesbery, LL Swift, TJ Montine |
Journal of lipid research | 1998 |
Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins
Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM |
Journal of Neuroscience | 1998 |
ApoE, Alzheimer's Disease, and Recovery from Brain Stress
AD Roses, AM Saunders |
Annals of the New York Academy of Sciences | 1997 |
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
S Fazio, VR Babaev, AB Murray, AH Hasty, KJ Carter, LA Gleaves, JB Atkinson, MF Linton |
Proceedings of the National Academy of Sciences | 1997 |
Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease
A Merched, H Blain, S Visvikis, B Herbeth, C Jeandel, G Siest |
Journal of the Neurological Sciences | 1997 |
Advances in Molecular and Cell Biology
KJ Clemetson |
Advances in Molecular and Cell Biology | 1997 |
Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice
J Spangenberg, LK Curtiss |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1997 |
Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster
CM Allan, S Taylor, JM Taylor |
The Journal of biological chemistry | 1997 |
Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier
BV Zlokovic |
Life Sciences | 1996 |
Human apolipoprotein E: the Alzheimer's disease connection
DM Holtzman, AM Fagan |
The FASEB Journal | 1996 |
Murine bone marrow transplantation as a novel approach to studying the role of macrophages in lipoprotein metabolism and atherogenesis
S Fazio, MR Linton |
Trends in Cardiovascular Medicine | 1996 |
In Vivo Footprinting Analysis of the Hepatic Control Region of the Human Apolipoprotein E/C-I/C-IV/C-II Gene Locus
Q Dang, J Taylor |
The Journal of biological chemistry | 1996 |
Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall
H Shimano, J Ohsuga, M Shimada, Y Namba, T Gotoda, K Harada, M Katsuki, Y Yazaki, N Yamada |
Journal of Clinical Investigation | 1995 |
Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation
WA Boisvert, J Spangenberg, LK Curtiss |
Journal of Clinical Investigation | 1995 |
Relationship of apolipoproteins Al, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant period
VW Armstrong, E Schütz, M Kaltefleiter, M Luy, M Helmhold, E Wieland, B Ringe, M Oellerich |
European Journal of Clinical Investigation | 1995 |
Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall
H Shimano, J Ohsuga, M Shimada, Y Namba, T Gotoda, K Harada, M Katsuki, Y Yazaki, N Yamada |
Science | 1995 |
Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
S Bellosta, BP Nathan, M Orth, LM Dong, RW Mahley, RE Pitas |
The Journal of biological chemistry | 1995 |
The Human Apolipoprotein E Gene Is Negatively Regulated in Human Liver HepG2 Cells by the Transcription Factor BEF-1
DT Berg, DS Calnek, BW Grinnell |
The Journal of biological chemistry | 1995 |
Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease
T Lehtimki, T Pirttil, PD Mehta, HM Wisniewski, H Frey, T Nikkari |
Human Genetics | 1995 |
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels
P Knijff, AM van Maagdenberg, RR Frants, LM Havekes |
Human Mutation | 1994 |
Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides*
MC Cabezas, DW Erkelens, LA Kock, TW de Bruin |
European Journal of Clinical Investigation | 1994 |
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
MF Linton, RV Farese, G Chiesa, DS Grass, P Chin, RE Hammer, HH Hobbs, SG Young |
Journal of Clinical Investigation | 1993 |
Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters
JS Cohn, EJ Johnson, JS Millar, SD Cohn, RW Milne, YL Marcel, RM Russell, EJ Schaefer |
Journal of lipid research | 1993 |
Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus
NS Shachter, Y Zhu, A Walsh, JL Breslow, JD Smith |
Journal of lipid research | 1993 |
A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice
WS Simonet, N Bucay, SJ Lauer, JM Taylor |
The Journal of biological chemistry | 1993 |
Apolipoprotein B gene mutations affecting cholesterol levels
RV Farese, MF Linton, SG Young |
Journal of Internal Medicine | 1992 |
Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine
AH Lichtenstein, DL Hachey, JS Millar, JL Jenner, L Booth, J Ordovas, EJ Schaefer |
Journal of lipid research | 1992 |
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
G Chiesa, HH Hobbs, ML Koschinsky, RM Lawn, SD Maika, RE Hammer |
The Journal of biological chemistry | 1992 |
The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol
S Bellosta, RW Mahley, DA Sanan, J Murata, DL Newland, JM Taylor, RE Pitas |
Journal of Clinical Investigation | 1986 |
The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol
S Bellosta, RW Mahley, DA Sanan, J Murata, DL Newland, JM Taylor, RE Pitas |
Journal of Clinical Investigation | 1986 |